Agonist-antagonist combinations in opioid dependence: a translational approach

about

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.

P2860

Q47140416-866D3089-987C-4F79-8F6A-8AAD31E1FD1F

P2860

Agonist-antagonist combinations in opioid dependence: a translational approach

Item

http://www.wikidata.org/entity/Q35848930

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Agonist-antagonist combinations in opioid dependence: a translational approach

@ast

Agonist-antagonist combinations in opioid dependence: a translational approach

@en

type

Item

label

Agonist-antagonist combinations in opioid dependence: a translational approach

@ast

Agonist-antagonist combinations in opioid dependence: a translational approach

@en

prefLabel

Agonist-antagonist combinations in opioid dependence: a translational approach

@ast

Agonist-antagonist combinations in opioid dependence: a translational approach

@en

P1476

Agonist-antagonist combinations in opioid dependence: a translational approach

@en

P2093

P Mannelli

http://www.w3.org/2001/XMLSchema#string

P2860

Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay

Methadone at tapered doses for the management of opioid withdrawal

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

Antagonist treatment of opioid withdrawal translational low dose approach

Naltrexone shortened opioid detoxification with buprenorphine

Drug abuse: hedonic homeostatic dysregulation

Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats.

Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naïve healthy male volunteers under a naltrexone block.

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.

P304

17-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22448305

http://www.w3.org/2001/XMLSchema#string

P932

3311161

http://www.w3.org/2001/XMLSchema#string

Agonist-antagonist combinations in opioid dependence: a translational approach

about

P2860

P2860

Agonist-antagonist combinations in opioid dependence: a translational approach

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932